ISRCTN22114173
Completed
未知
Highly Active Antiretroviral Treatment (HAART) of Human Immunodeficiency Virus (HIV)-infection in a town in Cameroon: randomised controlled study to suggest which treatment starting point is most beneficial for the patients
Institute of Community Medicine, University of Tromsø (Norway)0 sites100 target enrollmentJuly 6, 2007
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- HIV infection
- Sponsor
- Institute of Community Medicine, University of Tromsø (Norway)
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Treatment naive Human Immunodeficiency Virus (HIV)\-infected individuals
- •2\. 16 years of age or older
- •3\. CD4 count between 450 and 250 cells/mm^3
Exclusion Criteria
- •1\. If patient fulfils current indications for immediate treatment: CD4 less than 250 cells/mm^3 or WHO clinical stage 3 or 4
- •2\. If CD4 is currently greater than 450 cells/mm^3 . This is because patient will probably not start Anti\-Retroviral Therapy (ART) during the first year to come
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308
Completed
Not Applicable
Impact of highly active anti-retroviral therapy (HAART) during pregnancy and breastfeeding on mother-to-child transmission (MTCT) and mother's healthHuman immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)Infections and InfestationsHuman immunodeficiency virus (HIV)ISRCTN71468401World Health Organization (WHO) (Switzerland)2,400
Completed
Not Applicable
Highly Active Antiretroviral Therapy and Cardiovascular Risk factor profiles of HIV-infected Subjects in Nigeria: a cross-sectional studyHypertensionJPRN-UMIN000027983niversity of Warwick Benue State University Teaching Hospital400
Completed
Not Applicable
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trialISRCTN48682427Ministry of Health (Brazil)
Recruiting
Not Applicable
antiretroviral therapy regimen intensified with maraviroc during early HIV-1 infectioHIV-1 infectionJPRN-UMIN000017975ational Hospital Organization Osaka National Hospital30